Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
179 Cards in this Set
- Front
- Back
In plasma protein disorders, dx is difficult due to:
|
variable bleeding times,
wide range of PLT abnormalities wide range of PTT |
|
In plasma protein disorders like vWD, PT is:
|
normal
|
|
In plasma protein disorders like vWD, PTT is:
|
prolonged in severe
|
|
Type III plasma protein disorder is the _____ of vWF and is most ______.
|
absence, severe
|
|
vWD affects what factor?
|
8
|
|
How do you define disease level in VWD?
|
Factor 8 Level & vWF antigen determination
|
|
In VWD, CBC is:
|
normal
|
|
If you have type 1 vWD, tx =
|
DdAVP - stimulate release of endothelial stores of vWF
|
|
If you have type 2 & 3 vWD, tx =
|
Cryoprecipitate
|
|
if acquired vWD, tx with:
|
Cryoprecipitate (severe) or DdAVP (mild)
|
|
PT checks
|
factor VII dependent pathways
|
|
abnormalities of PT are due to
|
- Vit K deficiency & warfarin
- liver disease - DIC - factor deficiency (7, 5, 10, 2 [1572]) - factor inhibitor |
|
PTT measures:
|
Factor 10, 9, & 8 dependent pathways
|
|
PTT can be abnormal due to:
|
- heparin
- DIC - lupus anticoagulant - factor deficiency ( 11, 9, 8, 5, 10, 2) - factor inhibitor |
|
THrombin time measures
|
fibrinogen
|
|
Thrombin time is abnormal due to:
|
- heparin
- DIC - hypofibinogenemia - dysfibrinogenemia |
|
Platelet function analysis is tested:
|
- platelet
- vWF |
|
A mixing study is tested by:
|
presence of an inhibitor
|
|
Platelet function analysis is abnormal due to:
|
aspirin
vWD storage pool disease |
|
An abnormal mixing study may be due to:
|
abnormal clotting time corrects with deficiency; does not correct with an inhibitor
|
|
1 unit of platelets transfused raises platelets:
|
10K
|
|
platelets form hemostatic plug; platelets form from:
|
megakaryocytes
|
|
megakaryocytes matures in bone marrow in response to lineage specific cytokine,
|
thrombopoietin
|
|
Extrinisic Pathway =
|
initial pathway:
7a to 7 7 to 9 to 9a 7 to 10 to 10a in presence of Ca++ |
|
the extrinisic pathway is downregulated by:
|
tissue pathway factor inhibitor (TPFI)
|
|
TPFI bins to:
|
7a & 10
|
|
what is needed to stimulate intrinsic factors?
|
extrinisic factors
|
|
Secondary hemostasis is
|
the development of a fibrin clot
|
|
extrinisic hemostasis is:
|
tissue thromboplastin
|
|
intrinsic hemostatis is:
|
platelet thromboplastin
|
|
primary coagulation is
|
the formation of a platelet plug
|
|
Secondary hemostasis
|
is extrinisic, intrinsic & common pathways - fibrin plug
|
|
Sustained procoagulant response requires incorporation of components of:
|
intrinsic pathway
|
|
Intrinsic pathway:
|
thrombin activates 11, 5, 8
11a activates 9 which activates 9a 9a + 8a & Ca++ and phospholipid to form IF 10a-ase complex Xa interacts with 5a (+Ca) to form prothrombinase Prothrombinase turns prothrombin into thrombin |
|
Prothrombinase complex turns what into what
|
prothrombin into thrombin
|
|
Thrombin cleaves
|
fibrinogen to form fibrin
|
|
Fibrin is cross linked by ____ to result in a clot that is:
|
8a
resistant to lysis |
|
Thrombin functions
|
activates: 5, 8, 9
activates platelet exposing procoag phospholipid involves release of PLT activating substance - thromboxane, Ca, ADP, vWF activates 13 activates protein C |
|
Drugs that strongly inhibit/affect platelet fxn
|
strong inhibitors:
Clopidigrel Abciximab ASA NSAIDS "Strong inhibitions are lost in CanAAN" |
|
Drugs that moderately inhibit platelet fxn
|
Moderate
Heparin Abx (PCN, cephalosporin, nitrofurantoin) Dextran Fibrinolytics Hetastarch "I was moderately inhibited when I HAD to give my FH" |
|
Drugs that are weak platelet inhibitors
|
Weak
- alcohol - nitroglycerin - nitroprusside ANN is weakly inhibited when she drinks |
|
Liver is the site of what coag proteins
|
many - esp. 5 & 7
|
|
T/F
Liver is not responsible for coag factor 8 production |
True
|
|
What factors require Vit K for activity?
|
1972
(2, 10, 9, 7) and protein c & S |
|
What factors do not require vitamin K for activity?
|
5, 11, 12, fibrinogen, antithrombin 3
|
|
In liver disease, what increase?
|
Factor 8, vWF
|
|
Liver disease has a ___ PT and a ___ PTT
|
Increased PT
Normal PTT unless severe |
|
If problems with secondary hemostatis, bleeding problems much more severe and result in:
|
joint/muscle hemorrhage - hemarthrosis
easy bruising bleeding after trauma/surgery |
|
TCT
|
thrombin clot time
|
|
Bleeding time is used to assess what coag system
|
primary
|
|
bleeding time looks at what fxn?
|
platelet
|
|
INR is a measurement of:
|
PT/Vitamin K activity that has been corrected for lab variation
|
|
INR WNL =
|
1
|
|
INR 2 -3 =
|
therapeutic in CVT (cerebral venous thrombosus?)
|
|
INR 2.5 - 3.5
|
therapeutic for valvular
|
|
TCT or thrombin clot time is a measure of
|
acitivity of fibrinogen
|
|
T/F
Factor 7 is in the intrinsic pathway |
false!
in extrinsic |
|
Antiplatelet therapies include:
|
ASA
NSAIDS Clopidigrel Dypyridamole Prostacyclin Abciximab Integrillin Lamifiban Tirofiban Xemilofiban |
|
In Hemophilia A(8), what is the PT, PTT, TT
|
PT = normal
PTT= prolonged TT = normal |
|
In Hemophilia B (9), what is the PT, PTT, TT
|
PT =normal
PTT= prolonged TT = normal |
|
Hemophilia 8 is x-linked recessive yet its manifestations depend on the amount of:
|
Factor 8 deficiency
|
|
What characteristics are found in both hemophilia 8 & 9:
|
x-linked recessive
increased PTT WNL - PT, BT, fibrinogen No NSAIDS or ASA Avoid IM injections Hemarthrosis |
|
What is the hallmark of hemophilia A?
|
prolonged PTT
|
|
What is the management of Hemophilia A?
|
DdAVP - increases factor 8 activity
|
|
patients with severe Hemophilia 8 get what tx
|
cryoprecipitate
|
|
What should pt with hemophilia A avoid
|
ASA
antiplatelets IM injections |
|
What is leading COD with hemophilia?
|
AIDS
HEP B HEP C |
|
T/F
Hemophilia B is clinically identical to Hemophilia A |
True
|
|
Deficiency of Factor V leads to ___ PT, ___ PTT
|
Increased PT
Increased PTT |
|
What is etiology of Factor V deficiency?
|
liver disease in some cases
|
|
Tx of Factor V deficiency =
|
FFP or platelets
|
|
Deficiency of Factor VII is ____ and has a ___ PT, ____ PTT, ____TCT
|
rare
Increased PT normal PTT normal TCT |
|
Defciency of factor X is ____ and has a ___ PT, ____ PTT.
|
rare
Increased PT Increased PTT |
|
Tx of factor X =
|
plasma
|
|
patients with severe Hemophilia 8 get what tx
|
cryoprecipitate
|
|
What should pt with hemophilia A avoid
|
ASA
antiplatelets IM injections |
|
What is leading COD with hemophilia?
|
AIDS
HEP B HEP C |
|
T/F
Hemophilia B is clinically identical to Hemophilia A |
True
|
|
Deficiency of Factor V leads to ___ PT, ___ PTT
|
Increased PT
Increased PTT |
|
What is etiology of Factor V deficiency?
|
liver disease
|
|
Tx of Factor V deficiency =
|
FFP or platelets
|
|
Deficiency of Factor VII is ____ and has a ___ PT, ____ PTT, ____TCT
|
rare
Increased PT normal PTT normal TCT |
|
Defciency of factor X is ____ and has a ___ PT, ____ PTT.
|
rare
Increased PT Increased PTT |
|
Tx of factor X =
|
plasma
|
|
T/F
newborns are often deficient in Vit K |
Ture
|
|
Halmark of Vit K deficiency =
|
increased PT due to short 1/2 life of VII - thus cannot activate extrinisic pathway & increased PT
|
|
Vitamin K is responsible for the activation of:
|
7, 9, 10, 2
|
|
If Vit K deficiency is due to liver disease, waht will labs look like?
|
Increased AST/ALT
Increased bili Increased PT Normal PTT |
|
In prolonged Vit K deficiency, what gets messed up in intrinsic pathway
|
2, 3, 9, 10
also has prolonged PTT |
|
Manifestations of Vit K deficiency =
|
bleeding
|
|
Tx of VIt K deficiency
|
replace Vit K - AquaMEPHYTON
|
|
What is the best way to deliver K in Coumadin excess?
|
oral
|
|
In emergency vit K deficiency/coumadin OD, what can you use
|
FFP
|
|
Propagation of DIC due to failure to:
|
clear activated factors and due to reduced regulatory proteins (ATIII, protein C)
|
|
In liver disease, platelet dysfunction due to:
|
abnormal proteins, enzymes
|
|
Liver disease has increased fibrinolysis due to:
|
increased tPA
|
|
What is the best indicator of acute liver function?
|
Increased PT - b/c factor 7 short half life
|
|
In liver disease, what do labs look like?
|
Increased PTT (severe)
Increased fibrin split Decreased platelets All coag factors down but 8 |
|
If factor 8 is decreased in liver disease, what should you do?
|
think of another dx
|
|
what are other good measure of liver fxn?
|
Prealbumin & albumin
|
|
Causes of DIC
|
gram - bacteremia
trauma closed head injury burns hypotension/hypoperfusion adenocarcinoma acute promyelocytic leukemia vasculitis giant hemangioma aortic aneurysm cardiac mural thrombus snake venom activated factor infusions |
|
What gets activated in DIC
|
intrinsic in coag
extrinsic in CA and tumor mass |
|
In DIC, the procoagulant response is activated intravascularly which leads to:
|
diffuse thrombin production
|
|
In DIC you see multiple_____, _____ and ______.
|
multiple fibrin thrombi, tissue ischemia, end organ damage
|
|
DIC also activates what:
|
fibrinolytic pathway - leads to fibrin degradation
|
|
Labs in DIC
|
Increased PT
Increased PTT Decreased PLT Increased fibrin split products - d dimers + Schistocytes on peripheral smear |
|
How do you tx DIC
|
tx underlying disease
replace clotting factor Heparin contraversial but often used (destabilize clots before ischemia) |
|
Trousseau's -
|
malignancy associated with DIC; proteins w/both primary & secondary
|
|
What is the counter to coagulation?
|
natural anitcoagulants & fibrinolytic pathway
|
|
natural anitcoagulants & fibrinolytic pathway exist to
|
downregulate each step of procoag response
|
|
TFPI down regulates:
|
initial step - via antithrombin 3 & protein C
|
|
Antithrombin 3 neutralizes:
|
2a
10a 11a 12a |
|
Protein C inactivates
|
5a
8a |
|
Mechanism for clot removal during course of vascular repair =
|
plasminogen - plasmin via tPA
Plasmin degrades fibrin clot |
|
Inherited causes of thrombophilia
|
Activated protein C resistance/factor 5
Homocystelinemia Prothrombin 20210A Antithrombin 3 deficiency Protein C Protein S TPA deficiency Plasminogen activator inhibitor excess Dysfibrinogenemia Decreased plasminogen |
|
Meds that are acquired causes of thrombosis
|
HIT
OCPs HRT Prothrombin complexes |
|
Lab evaluatio of venous thrombosis will point to:
|
Factor V (biggest)
Lupus anticoag anticardiolipin homocysteine level prothrombin 20210A Antithrombin 3 activity Protein C activity Protein S activity |
|
T/F hemolytic anemia causes increased thrombosis
|
true
|
|
T/F nephrotic syndrome causes increased thrombosis
|
true
|
|
T/F artificial heart valves cause increased thrombosis
|
true
|
|
Risk of getting cancer
|
1:2 men
1:3 women |
|
#1 death rate in women & men
|
lung CA
|
|
what are the good things that protect us from cancer and the bad things that allow cancer to get turned on?
|
good = tumor suppressor genes
bad = oncogenes |
|
Tobacco CA effects
|
lung
bronchus esophagus head & neck stomach pancreas kidney bladder cervical prostate |
|
Inherited causes of thrombophilia
|
Activated protein C resistance/factor 5
Homocystelinemia Prothrombin 20210A Antithrombin 3 deficiency Protein C Protein S TPA deficiency Plasminogen activator inhibitor excess Dysfibrinogenemia Decreased plasminogen |
|
Meds that are acquired causes of thrombosis
|
HIT
OCPs HRT Prothrombin complexes |
|
Lab evaluatio of venous thrombosis will point to:
|
Factor V (biggest)
Lupus anticoag anticardiolipin homocysteine level prothrombin 20210A Antithrombin 3 activity Protein C activity Protein S activity |
|
T/F hemolytic anemia causes increased thrombosis
|
true
|
|
T/F nephrotic syndrome causes increased thrombosis
|
true
|
|
T/F artificial heart valves cause increased thrombosis
|
true
|
|
Risk of getting cancer
|
1:2 men
1:3 women |
|
#1 death rate in women & men
|
lung CA
|
|
what are the good things that protect us from cancer and the bad things that allow cancer to get turned on?
|
good = tumor suppressor genes
bad = oncogenes |
|
Tobacco CA effects
|
lung
bronchus esophagus head & neck stomach pancreas kidney bladder cervical prostate |
|
high etoh causes what kinds of Ca
|
liver
rectum breast oralcavity pharynx larynx esophagus |
|
being obese or having a high fat diet increases your risk of CA where?
|
colon
breast endometrium kidney pancreas esophagus |
|
#1 environmental carcinogen
|
tobacco
|
|
alkylating agents for chemo can induce
|
AML
|
|
What induces lymphoma
|
immunosuppressants, radiation
|
|
what CAs do statins protect agains
|
breast
colon prostate |
|
OCPs protect against what CA
|
ovarian
|
|
what is protective in colon CA
|
folic acid
NSAIDS Statins |
|
good cost benefit in cancer screening
|
mammo & pap
|
|
bad cost benefit
|
CEA
BRCA 1 & 2 |
|
loss or suppression of TP53 can lead to what CA
|
sarcoma, breast, brain, adrenal
|
|
c-myc mutation can lead to
|
Burkitt's lymphoma, neuroblastoma
|
|
CLL has a mutation of
|
bcl2
|
|
If pt has increased ACTH, what CA might he have?
|
oat cell
Cushing:oat |
|
If pt has increased ADH, what CA might he have?
|
Small cell lung
SIADH: lung |
|
If pt has increased HcG, what CA might he have?
|
germ cell tumors, lung CA
hCG: germ-lung |
|
What can happen in CA that effects the kidneys that is a medical emergency?
|
hypercalcemia
|
|
In radiation how is the following affected in early and late complications?
Bone marrow |
early - aplasia
late - leukemia, myelodysplasia |
|
In radiation how is the following affected in early and late complications?
Heart |
Early - none
Late - pericarditis, cardiomyopathy, coronary disease |
|
In radiation how is the following affected in early and late complications?
Rectum |
early - diarrhea, tesemsus
late - stricture, obstruction |
|
chemo sis the major tx inL
|
60% of Ca
|
|
doxorubicin side effects =
|
alopecia
cardiomyopathy |
|
MXT side effects =
|
stomatitis - give folic acid
|
|
Cisplatin side effects =
|
renal failure
|
|
what cancers are more likely to get hypercalcemia
|
breast, MM (#1), osteolytic CA
|
|
chemo sis the major tx inL
|
60% of Ca
|
|
doxorubicin side effects =
|
alopecia
cardiomyopathy |
|
MXT side effects =
|
stomatitis - give folic acid
|
|
chemo sis the major tx inL
|
60% of Ca
|
|
chemo sis the major tx inL
|
60% of Ca
|
|
Cisplatin side effects =
|
renal failure
|
|
doxorubicin side effects =
|
alopecia
cardiomyopathy |
|
doxorubicin side effects =
|
alopecia
cardiomyopathy |
|
what cancers are more likely to get hypercalcemia
|
breast, MM (#1), osteolytic CA
|
|
MXT side effects =
|
stomatitis - give folic acid
|
|
MXT side effects =
|
stomatitis - give folic acid
|
|
Cisplatin side effects =
|
renal failure
|
|
Cisplatin side effects =
|
renal failure
|
|
what cancers are more likely to get hypercalcemia
|
breast, MM (#1), osteolytic CA
|
|
what cancers are more likely to get hypercalcemia
|
breast, MM (#1), osteolytic CA
|
|
Use hormone therapy when:
|
estrogen receptor + disease
lymph node, skin, bone, mets >2 y from completion of adjuvant therapy |
|
use chemi when:
|
receptor - disease
lung/liver involvement < 2 y from completion of adjuvant therapy progression after use of 1st & 2nd line chemo |
|
EBV increases risk of
|
Burkitts
|
|
Conjugate estrogens taken ____ y = increased risk of what?
|
< 5-10
breast and endometrial cancer 5x if no progesterone taken |
|
Management of hypercalcemia =
|
IV fluids
good urine output pamidronate |